Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death
Yujeong Moon, M. Shim, Jiwoong Choi, Suah Yang, Jinseong Kim, W. Yun, Hanhee Cho, Jung Yeon Park, Yongju Kim, J. Seong, Kwangmeyung Kim
Theranostics